Electron transfer-based antioxidant nanozymes: Emerging therapeutics for inflammatory diseases

Jingnan Zhao1, Fanfan Guo1, Lin Hou2

  • 1School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, PR China.

Insights

Reactive oxygen species (ROS) worsen inflammatory diseases. Antioxidant nanozymes offer a promising therapeutic strategy by scavenging ROS and reducing oxidative stress.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Nanotechnology

Background:

  • Inflammatory diseases are characterized by elevated reactive oxygen species (ROS).
  • Excess ROS contribute to macrophage polarization, DNA damage, and cellular damage, exacerbating inflammation.
  • Scavenging ROS via antioxidant strategies is crucial for managing inflammatory conditions.

Purpose of the Study:

  • To review the fundamental knowledge of ROS and associated diseases.
  • To summarize active centers for developing antioxidant nanozymes.
  • To discuss strategies for enhancing nanozyme catalytic activity and their therapeutic applications.

Main Methods:

  • Review of literature on ROS, inflammatory diseases, and nanozyme development.
  • Analysis of strategies for designing antioxidant nanozymes with improved catalytic efficiency.
  • Discussion of current applications of nanozymes in treating inflammatory diseases.

Main Results:

  • Nanozymes inspired by natural enzymes show potential as electron transfer-based therapeutics.
  • Specific active centers and design strategies can enhance nanozyme antioxidant activity.
  • Developed nanozymes demonstrate efficacy in preclinical models of inflammatory diseases.

Conclusions:

  • Antioxidant nanozymes represent a promising therapeutic avenue for inflammatory diseases.
  • Further research into nanozyme design and application can optimize their biomedical potential.
  • Nanozymes offer a novel approach to combatting oxidative stress in disease therapy.